SCHEMBL31679415

SCHEMBL31679415

CCC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]1C[C@@H](O)CN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CS)[C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ MAPK8 P45983 1/20 0.47
▸ MAPK9 P45984 1/20 0.47
▸ MAPK10 P53779 1/20 0.47
▸ KEAP1 Q14145 2/20 0.46
▸ AGTR1 P30556 1/20 0.46
▸ AGTR2 P50052 1/20 0.46
▸ NTSR2 O95665 2/20 0.46
▸ NTSR1 P30989 2/20 0.46
▸ KISS1R Q969F8 4/20 0.45
▸ OPRM1 P35372 2/20 0.45
▸ NMUR2 Q9GZQ4 2/20 0.45
▸ NMUR1 Q9HB89 2/20 0.45
▸ OPRD1 P41143 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31679412 0.97 MAPK8 (0.50) MAPK8MAPK9MAPK10KEAP1NTSR2
SCHEMBL31679441 0.96 NTSR1 (0.51) MAPK8MAPK9MAPK10KEAP1NTSR2
SCHEMBL31679452 0.95 F2 (0.49) MAPK8MAPK9MAPK10KEAP1AGTR1
SCHEMBL31679423 0.94 AGTR2 (0.51) MAPK8MAPK9MAPK10AGTR1AGTR2
SCHEMBL31679451 0.92 AGTR2 (0.52) MAPK8MAPK9MAPK10AGTR1AGTR2
SCHEMBL31679462 0.92 AGTR2 (0.52) MAPK8MAPK9MAPK10AGTR1AGTR2
SCHEMBL31679409 0.92 OPRD1 (0.49) MAPK8MAPK9MAPK10KEAP1AGTR1
SCHEMBL31679406 0.91 MAPK8 (0.51) MAPK8MAPK9MAPK10AGTR1AGTR2
SCHEMBL31679381 0.91 AGTR2 (0.50) MAPK8MAPK9MAPK10AGTR1AGTR2
SCHEMBL31679388 0.91 OPRD1 (0.50) MAPK8MAPK9MAPK10AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4610269-A1 UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR (UPAR) LIGANDS FOR DIAGNOSTIC OR THERAPEUTIC USE 3B Pharmaceuticals GmbH (DE) 2025-09-03 — — EP disclosed
Send feedback